-
Sponsored by Wanhuida Intellectual PropertyJianhui Li of Wanhuida Intellectual Property explains how China addresses the question of whether the features of an administration process limit a patented product and distinguish it from prior art -
Sponsored by Wanhuida Intellectual PropertyYue Guan of Wanhuida Intellectual Property reports on a case in China that has implications for the drafting of compound patents incorporating Markush claims
-
Sponsored by Liu, Shen & AssociatesGuanyang Yao and Ran Wang of Liu, Shen & Associates weigh up the pros and cons of pursuing both civil litigation and administrative action when seeking IP protection in China
-
Sponsored by AFD China Intellectual Property Law OfficeXue Li, Jingjing Wu and Mingzhao Yang of AFD China Intellectual Property Law Office review China’s recent high-level decisions on trademark ‘use’, with valuable lessons for infringement
-
Sponsored by HFG Law & Intellectual PropertyFabio Giacopello and Daniel de Prado Escudero of HFG Law & Intellectual Property analyse how the applicability of trademarks has evolved amid the widespread use of original equipment manufacturers in China by overseas companies
-
Sponsored by CCPIT Patent and Trademark Law OfficeGang Hu and Hongxia Wu of CCPIT Patent and Trademark Law Office use practical knowledge to illustrate the evidence rights holders need to effectively protect their IP and win significant damages in China
-
Sponsored by DEQI Intellectual Property Law CorporationYingping Song of DEQI Intellectual Property clarifies the complexities surrounding divisional application strategies in China
-
Sponsored by Chang Tsi & PartnersMichael Wu and Darren Leng of Chang Tsi & Partners analyse China’s new Patent Law, as the country strives for a competitive IP protection platform on the global stage
-
Sponsored by Wanhuida Intellectual PropertyFeng Zheng and Xiaoyang Yang of Wanhuida outline the various defence mechanisms patentees have at their disposal when facing infringement accusations in China
-
Sponsored by Hanol IP & LawMin Son of Hanol IP & Law finds encouragement for developers of new chemical entity drugs after the rulings handed down in a battle between AstraZeneca and several generic pharmaceutical companies
-
Sponsored by Tilleke & GibbinsForeign investment in Myanmar is expected to receive a boost as a result of changes to the country’s trademark application process, report Khin Myo Myo Aye and Khin Yadanar Htay of Tilleke & Gibbins
-
Sponsored by Tilleke & GibbinsLinh Thi Mai Nguyen of Tilleke & Gibbins explains why an increase in trademark agents and intellectual property representation service organisations can be expected because of new legislation in Vietnam
